Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 1-year, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the efficacy of zoledronic acid 5 mg (Aclasta®) on bone mineral density in patients with multiple sclerosis followed by a 1-year open-label treatment phase https://kusajili.com:443/Trial/QcMltbfUVUikHefUNpSObQ%24a-1-year-multicenter-double-blind-randomized-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-of-zoledronic-aci
I have read and accept the terms of use of the site and the Privacy Policy
Send your message